Prevention of Cancer in the Upper Gastrointestinal Tract with COX-Inhibition. Still an Option?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|22|2261-2273

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.22, 2007-08, pp. : 2261-2273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual COX Inhibition and Upper Gastrointestinal Damage

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2191-2195

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2253-2266

Bentham Science Publishers

Access to resources Recommend Favorite

Low Dose Aspirin, COX-Inhibition and Chemoprevention of Colorectal Cancer

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 5, 2005-06 ,pp. : 493-503

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2 inhibition has potential for lung cancer prevention

By  

Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Mechanisms of Colon Cancer Prevention with and Beyond COX-2 Inhibition

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 5, 2005-01 ,pp. : 505-516

Bentham Science Publishers

Access to resources Recommend Favorite